Global Tonic-Clonic Seizures Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08253448

Publication Date:

August 19, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic鈥揷lonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.
The global Tonic-Clonic Seizures market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淭onic-Clonic Seizures Industry Forecast鈥� looks at past sales and reviews total world Tonic-Clonic Seizures sales in 2023, providing a comprehensive analysis by region and market sector of projected Tonic-Clonic Seizures sales for 2024 through 2030. With Tonic-Clonic Seizures sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tonic-Clonic Seizures industry.
This Insight Report provides a comprehensive analysis of the global Tonic-Clonic Seizures landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tonic-Clonic Seizures portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Tonic-Clonic Seizures market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tonic-Clonic Seizures and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tonic-Clonic Seizures.
The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.
This report presents a comprehensive overview, market shares, and growth opportunities of Tonic-Clonic Seizures market by product type, application, key players and key regions and countries.
Segmentation by type
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acid
Others
Segmentation by application
Hospitals
Clinics
Academic and Research Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Johnson & Johnson
UCB Celltech
Abbott Laboratories
GlaxoSmithKline
Novartis
Sanofi
Takeda
Teva Pharmaceutical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tonic-Clonic Seizures Market Size 2019-2030
2.1.2 Tonic-Clonic Seizures Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tonic-Clonic Seizures Segment by Type
2.2.1 Barbiturates
2.2.2 Hydantoin
2.2.3 Phenyltriazine
2.2.4 Iminostilbenes
2.2.5 Benzodiazepines
2.2.6 Aliphatic Carboxylic Acid
2.2.7 Others
2.3 Tonic-Clonic Seizures Market Size by Type
2.3.1 Tonic-Clonic Seizures Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tonic-Clonic Seizures Market Size Market Share by Type (2019-2024)
2.4 Tonic-Clonic Seizures Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academic and Research Centers
2.4.4 Others
2.5 Tonic-Clonic Seizures Market Size by Application
2.5.1 Tonic-Clonic Seizures Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tonic-Clonic Seizures Market Size Market Share by Application (2019-2024)
3 Tonic-Clonic Seizures Market Size by Player
3.1 Tonic-Clonic Seizures Market Size Market Share by Players
3.1.1 Global Tonic-Clonic Seizures Revenue by Players (2019-2024)
3.1.2 Global Tonic-Clonic Seizures Revenue Market Share by Players (2019-2024)
3.2 Global Tonic-Clonic Seizures Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Tonic-Clonic Seizures by Regions
4.1 Tonic-Clonic Seizures Market Size by Regions (2019-2024)
4.2 Americas Tonic-Clonic Seizures Market Size Growth (2019-2024)
4.3 APAC Tonic-Clonic Seizures Market Size Growth (2019-2024)
4.4 Europe Tonic-Clonic Seizures Market Size Growth (2019-2024)
4.5 Middle East & Africa Tonic-Clonic Seizures Market Size Growth (2019-2024)
5 Americas
5.1 Americas Tonic-Clonic Seizures Market Size by Country (2019-2024)
5.2 Americas Tonic-Clonic Seizures Market Size by Type (2019-2024)
5.3 Americas Tonic-Clonic Seizures Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tonic-Clonic Seizures Market Size by Region (2019-2024)
6.2 APAC Tonic-Clonic Seizures Market Size by Type (2019-2024)
6.3 APAC Tonic-Clonic Seizures Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tonic-Clonic Seizures by Country (2019-2024)
7.2 Europe Tonic-Clonic Seizures Market Size by Type (2019-2024)
7.3 Europe Tonic-Clonic Seizures Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tonic-Clonic Seizures by Region (2019-2024)
8.2 Middle East & Africa Tonic-Clonic Seizures Market Size by Type (2019-2024)
8.3 Middle East & Africa Tonic-Clonic Seizures Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Tonic-Clonic Seizures Market Forecast
10.1 Global Tonic-Clonic Seizures Forecast by Regions (2025-2030)
10.1.1 Global Tonic-Clonic Seizures Forecast by Regions (2025-2030)
10.1.2 Americas Tonic-Clonic Seizures Forecast
10.1.3 APAC Tonic-Clonic Seizures Forecast
10.1.4 Europe Tonic-Clonic Seizures Forecast
10.1.5 Middle East & Africa Tonic-Clonic Seizures Forecast
10.2 Americas Tonic-Clonic Seizures Forecast by Country (2025-2030)
10.2.1 United States Tonic-Clonic Seizures Market Forecast
10.2.2 Canada Tonic-Clonic Seizures Market Forecast
10.2.3 Mexico Tonic-Clonic Seizures Market Forecast
10.2.4 Brazil Tonic-Clonic Seizures Market Forecast
10.3 APAC Tonic-Clonic Seizures Forecast by Region (2025-2030)
10.3.1 China Tonic-Clonic Seizures Market Forecast
10.3.2 Japan Tonic-Clonic Seizures Market Forecast
10.3.3 Korea Tonic-Clonic Seizures Market Forecast
10.3.4 Southeast Asia Tonic-Clonic Seizures Market Forecast
10.3.5 India Tonic-Clonic Seizures Market Forecast
10.3.6 Australia Tonic-Clonic Seizures Market Forecast
10.4 Europe Tonic-Clonic Seizures Forecast by Country (2025-2030)
10.4.1 Germany Tonic-Clonic Seizures Market Forecast
10.4.2 France Tonic-Clonic Seizures Market Forecast
10.4.3 UK Tonic-Clonic Seizures Market Forecast
10.4.4 Italy Tonic-Clonic Seizures Market Forecast
10.4.5 Russia Tonic-Clonic Seizures Market Forecast
10.5 Middle East & Africa Tonic-Clonic Seizures Forecast by Region (2025-2030)
10.5.1 Egypt Tonic-Clonic Seizures Market Forecast
10.5.2 South Africa Tonic-Clonic Seizures Market Forecast
10.5.3 Israel Tonic-Clonic Seizures Market Forecast
10.5.4 Turkey Tonic-Clonic Seizures Market Forecast
10.5.5 GCC Countries Tonic-Clonic Seizures Market Forecast
10.6 Global Tonic-Clonic Seizures Forecast by Type (2025-2030)
10.7 Global Tonic-Clonic Seizures Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Tonic-Clonic Seizures Product Offered
11.1.3 Pfizer Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Tonic-Clonic Seizures Product Offered
11.2.3 Johnson & Johnson Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 UCB Celltech
11.3.1 UCB Celltech Company Information
11.3.2 UCB Celltech Tonic-Clonic Seizures Product Offered
11.3.3 UCB Celltech Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 UCB Celltech Main Business Overview
11.3.5 UCB Celltech Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Tonic-Clonic Seizures Product Offered
11.4.3 Abbott Laboratories Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Tonic-Clonic Seizures Product Offered
11.5.3 GlaxoSmithKline Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Tonic-Clonic Seizures Product Offered
11.6.3 Novartis Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Tonic-Clonic Seizures Product Offered
11.7.3 Sanofi Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Tonic-Clonic Seizures Product Offered
11.8.3 Takeda Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Information
11.9.2 Teva Pharmaceutical Tonic-Clonic Seizures Product Offered
11.9.3 Teva Pharmaceutical Tonic-Clonic Seizures Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Main Business Overview
11.9.5 Teva Pharmaceutical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂